These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

794 related articles for article (PubMed ID: 9282816)

  • 1. Production and characterization of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins.
    Babas T; Le Grand R; Dormont D; Bahraoui E
    AIDS Res Hum Retroviruses; 1997 Sep; 13(13):1109-19. PubMed ID: 9282816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and epitope mapping of neutralizing monoclonal antibodies produced by immunization with oligomeric simian immunodeficiency virus envelope protein.
    Edinger AL; Ahuja M; Sung T; Baxter KC; Haggarty B; Doms RW; Hoxie JA
    J Virol; 2000 Sep; 74(17):7922-35. PubMed ID: 10933700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralizing monoclonal antibody against a external envelope glycoprotein (gp110) of SIVmac251.
    Matsumi S; Matsushita S; Yoshimura K; Javaherian K; Takatsuki K
    AIDS Res Hum Retroviruses; 1995 Apr; 11(4):501-8. PubMed ID: 7632464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity and neutralizing capacity of three monoclonal antibodies produced against the envelope glycoprotein of simian immunodeficiency virus isolate 251.
    Babas T; Belhadj-Jrad B; Le Grand R; Dormont D; Montagnier L; Bahraoui E
    Virology; 1995 Aug; 211(1):339-44. PubMed ID: 7544048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain.
    Cole KS; Alvarez M; Elliott DH; Lam H; Martin E; Chau T; Micken K; Rowles JL; Clements JE; Murphey-Corb M; Montelaro RC; Robinson JE
    Virology; 2001 Nov; 290(1):59-73. PubMed ID: 11883006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fine analysis of humoral antibody response to envelope glycoprotein of SIV in infected and vaccinated macaques.
    Silvera P; Flanagan B; Kent K; Rud E; Powell C; Corcoran T; Bruck C; Thiriart C; Haigwood NL; Stott EJ
    AIDS Res Hum Retroviruses; 1994 Oct; 10(10):1295-304. PubMed ID: 7848685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of serum antibody reactivities to a conformational and to linear antigenic sites in the external envelope glycoprotein of simian immunodeficiency virus (SIVmac) induced by infection and vaccination.
    McBride BW; Corthals G; Rud E; Kent K; Webster S; Cook N; Cranage MP
    J Gen Virol; 1993 Jun; 74 ( Pt 6)():1033-41. PubMed ID: 7685372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a neutralizing domain in the external envelope glycoprotein of simian immunodeficiency virus.
    Benichou S; Legrand R; Nakagawa N; Faure T; Traincard F; Vogt G; Dormont D; Tiollais P; Kieny MP; Madaule P
    AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1165-70. PubMed ID: 1380263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of monoclonal antibodies to human immunodeficiency virus type 2 envelope glycoproteins.
    Traincard F; Rey-Cuillé MA; Huon I; Dartevelle S; Mazié JC; Benichou S
    AIDS Res Hum Retroviruses; 1994 Dec; 10(12):1659-67. PubMed ID: 7888225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simian immunodeficiency virus (SIV) envelope-specific Fabs with high-level homologous neutralizing activity: recovery from a long-term-nonprogressor SIV-infected macaque.
    Glamann J; Burton DR; Parren PW; Ditzel HJ; Kent KA; Arnold C; Montefiori D; Hirsch VM
    J Virol; 1998 Jan; 72(1):585-92. PubMed ID: 9420262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production and of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins.
    Kent KA; Gritz L; Stallard G; Cranage MP; Collignon C; Thiriart C; Corcoran T; Silvera P; Stott EJ
    AIDS; 1991 Jul; 5(7):829-36. PubMed ID: 1716442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of two neutralizing and 8 non-neutralizing epitopes on simian immunodeficiency virus envelope using monoclonal antibodies.
    Kent KA; Rud E; Corcoran T; Powell C; Thiriart C; Collignon C; Stott EJ
    AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1147-51. PubMed ID: 1380261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human herpesvirus-6 glycoprotein H and L homologs are components of the gp100 complex and the gH external domain is the target for neutralizing monoclonal antibodies.
    Liu DX; Gompels UA; Foa-Tomasi L; Campadelli-Fiume G
    Virology; 1993 Nov; 197(1):12-22. PubMed ID: 7692666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypervariable epitope constructs representing variability in envelope glycoprotein of SIV induce a broad humoral immune response in rabbits and rhesus macaques.
    Meyer D; Anderson DE; Gardner MB; Torres JV
    AIDS Res Hum Retroviruses; 1998 Jun; 14(9):751-60. PubMed ID: 9643375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic evolution of antibody populations in a rhesus macaque infected with attenuated simian immunodeficiency virus identified by surface plasmon resonance.
    Steckbeck JD; Grieser HJ; Sturgeon T; Taber R; Chow A; Bruno J; Murphy-Corb M; Montelaro RC; Cole KS
    J Med Primatol; 2006 Aug; 35(4-5):248-60. PubMed ID: 16872288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and characterization of two serotype independent monoclonal antibodies against foot-and-mouth disease virus.
    Yang M; Clavijo A; Suarez-Banmann R; Avalo R
    Vet Immunol Immunopathol; 2007 Jan; 115(1-2):126-34. PubMed ID: 17109972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the B and T cell immune response to the envelope glycoprotein 130 (gp130) of the macaque strain of simian immunodeficiency virus (SIVmac), induced by immunization of rhesus macaques with virus-derived or vaccinia virus-expressed gp130.
    Voss G; Dittmer U; Coulibaly C; Makoschey B; Petry H; Lüke W; Hunsmann G
    J Gen Virol; 1993 Sep; 74 ( Pt 9)():1757-63. PubMed ID: 8376957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of envelope glycoprotein-specific antibodies from SIV-infected and gp110-immunized monkeys in ACC and ADCC assays.
    Ohkawa S; Xu K; Wilson LA; Montelaro R; Martin LN; Murphey-Corb M
    AIDS Res Hum Retroviruses; 1995 Mar; 11(3):395-403. PubMed ID: 7786584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.
    Gromowski GD; Barrett AD
    Virology; 2007 Sep; 366(2):349-60. PubMed ID: 17719070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of monoclonal antibodies to the envelope proteins of an immunodeficiency virus of African green monkeys, SIVagmTYO-7.
    Otteken A; Nick S; Bergter W; Lüke W; Stahl-Hennig C; Peters JH; Voss G; Hunsmann G
    J Med Primatol; 1993 Jun; 22(4):263-8. PubMed ID: 7693947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.